Your browser doesn't support javascript.
loading
Generation of a human SLC12A3 knock-in human induced pluripotent stem cell line (CMCi014-A-82) using CRISPR-Cas9 system.
Woo Lim, Sun; In Lee, Kang; Cui, Sheng; Fang, Xianying; Jin Shin, Yoo; Lee, Hanbi; Woo Yang, Chul; Young Lee, Jae; Ha Chung, Byung.
Afiliação
  • Woo Lim S; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea.
  • In Lee K; R&D Center, ToolGen, Inc., Seoul, Republic of Korea.
  • Cui S; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Fang X; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jin Shin Y; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Lee H; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Woo Yang C; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Young Lee J; R&D Center, ToolGen, Inc., Seoul, Republic of Korea. Electronic address: jy.lee2@toolgen.com.
  • Ha Chung B; Transplant Research Center, College of Medcine, The Catholic University of Korea, Seoul, Republic of Korea; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: chungbh@catholic.ac.kr.
Stem Cell Res ; 81: 103522, 2024 Jul 31.
Article em En | MEDLINE | ID: mdl-39163808
ABSTRACT
Gitelman's disease is caused by a genetic mutation in the solute carrier family 12 member 3 (SLC12A3) gene, which encodes the sodium chloride cotransporter. In this study, we generated a stable human induced pluripotent stem cell (hiPSC) line, WTC11-SLC12A3 (CMCi014-A-82), by knocking in the entire SLC12A3 gene at the SHS231 locus in healthy wild-type control hiPSCs (WTC11). We verified that WTC11-SLC12A3 expressed pluripotency markers and exhibited normal stem cell morphology. Furthermore, this cell line maintains a normal karyotype and can differentiate into the three germ layers. Therefore, this cell line may provide a basis for gene therapy for Gitelman's disease.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Stem Cell Res Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Stem Cell Res Ano de publicação: 2024 Tipo de documento: Article País de publicação: Reino Unido